News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Chimerix, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
BioCapital
Ebola Clinical Trials: Big Name Players In The Ebola Race
October 20, 2014
·
12 min read
Bio NC
Chimerix, Inc. Slips As Ebola Patient On Brincidofovir Dies
October 10, 2014
·
2 min read
Drug Development
Chimerix, Inc. Says Brincidofovir Improved Survival In Study Spurred By Boy
October 8, 2014
·
2 min read
Chimerix, Inc.’s Brincidofovir An Ebola Standout For Traders, Says Analyst
October 2, 2014
·
1 min read
Bio NC
Josh Hardy Going Home After Getting Chimerix, Inc.'s Anti-Viral Drug Brincidofovir
July 18, 2014
·
1 min read
Did Chimerix, Inc. Set A Bad Example For Biopharma?
March 25, 2014
·
4 min read
Bio NC
Why Everyone Has A Stake In The Chimerix, Inc. Drug Offered To Dying Boy
March 13, 2014
·
1 min read
Pharm Country
Thousands Of Patients Warned About Possible Exposure to Hepatitis, HIV
March 12, 2014
·
1 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Chimerix Reports Fourth Quarter and Year End 2024 Financial Results
March 21, 2025
·
7 min read
Press Releases
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 7, 2025
March 10, 2025
·
1 min read
Press Releases
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
March 5, 2025
·
14 min read
Press Releases
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 18, 2025
February 19, 2025
·
1 min read
Press Releases
Chimerix Announces FDA Acceptance and Priority Review of New Drug Application for Dordaviprone as Treatment for Recurrent H3 K27M-Mutant Diffuse Glioma
February 18, 2025
·
3 min read
Press Releases
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 24, 2025
·
1 min read
Press Releases
Chimerix to Speak Today at The White House Cancer Moonshot Forum
January 14, 2025
·
3 min read
Press Releases
Chimerix Submits Dordaviprone New Drug Application for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma
December 30, 2024
·
4 min read
Press Releases
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 6, 2024
December 9, 2024
·
1 min read
Press Releases
Chimerix Announces Updated Phase 2 Response Assessment of Dordaviprone in Recurrent H3 K27M Glioma at the 2024 SNO Meeting
November 11, 2024
·
4 min read
